|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/18 | (2006.01) |
| A61P 27/02 | (2006.01) |
| (11) | Number of the document | 2283041 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09739513.1 |
| Date of filing the European patent application | 2009-04-27 | |
| (97) | Date of publication of the European application | 2011-02-16 |
| (45) | Date of publication and mention of the grant of the patent | 2015-09-02 |
| (46) | Date of publication of the claims translation | 2015-12-28 |
| (86) | Number | PCT/US2009/041785 |
| Date | 2009-04-27 |
| (87) | Number | WO 2009/134711 |
| Date | 2009-11-05 |
| (30) | Number | Date | Country code |
| 48431 P | 2008-04-28 | US | |
| 48689 P | 2008-04-29 | US |
| (72) |
HUANG, Arthur, J., US
KELLEY, Robert, F., US
LOWMAN, Henry, US
VAN LOOKEREN CAMPAGNE, Menno, US
WINTER, Charles, M., US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Humanizuoti anti-faktoriaus D antikūnai ir jų panaudojimas |
| HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2019-04-11 | 11 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-04-27 |